Literature DB >> 16256390

First characterization of a large deletion of the PDHA 1 gene.

Michèle Brivet1, Marie-Laure Moutard, Mokhtar Zater, Lydia Venet, Claude Chenel, Manuele Mine, A Legrand.   

Abstract

Pyruvate dehydrogenase complex (PDC) deficiency is one of the major recognized causes of congenital lactic acidosis. The most common form is due to PDHA 1 gene (Xp22.12) defects. Here, we report the case of a Polynesian girl presenting with delayed neurological development, cortical atrophy, and posterior corpus callosum agenesis. Elevated lactate and pyruvate levels in blood and cerebrospinal fluid suggested PDC deficiency. However, PDC activity was within the normal range in lymphocytes and the direct sequencing of the 11 exons and intron-exon junctions of the PDHA 1 gene did not show any changes. Long-range PCR amplification of the whole gene (16 kb) from blood DNA revealed a heterozygous deletion of approximately 4.2kb. Fine mapping of the deletion breakpoint was achieved using purified long-range PCR products for restriction enzyme analysis and direct sequencing. The deletion removed a 4,227 bp region covering part of intron 5 to part of intron 9 [g.10,145_14,371 del 4,227]. The deletion breakpoint contained a short direct repeat (GTAG), which may be derived either from the upstream or the downstream homologous sequence. The presence of a GAG triplet and inverted repeats in the vicinity of the deletion suggest replication slippage at a polymerase alpha arrest site. This is the first time that a large intragenic deletion of the PDHA 1 gene has been characterized.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16256390     DOI: 10.1016/j.ymgme.2005.08.009

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  5 in total

Review 1.  The spectrum of pyruvate dehydrogenase complex deficiency: clinical, biochemical and genetic features in 371 patients.

Authors:  Kavi P Patel; Thomas W O'Brien; Sankarasubramon H Subramony; Jonathan Shuster; Peter W Stacpoole
Journal:  Mol Genet Metab       Date:  2011-10-07       Impact factor: 4.797

2.  The spectrum of pyruvate dehydrogenase complex deficiency: clinical, biochemical and genetic features in 371 patients.

Authors:  Kavi P Patel; Thomas W O'Brien; Sankarasubramon H Subramony; Jonathan Shuster; Peter W Stacpoole
Journal:  Mol Genet Metab       Date:  2012-07       Impact factor: 4.797

3.  Down-regulation of expression of rat pyruvate dehydrogenase E1alpha gene by self-complementary adeno-associated virus-mediated small interfering RNA delivery.

Authors:  Zongchao Han; Marina Gorbatyuk; James Thomas; Alfred S Lewin; Arun Srivastava; Peter W Stacpoole
Journal:  Mitochondrion       Date:  2007-02-20       Impact factor: 4.160

4.  The role of glycolysis and mitochondrial respiration in the formation and functioning of endothelial tip cells during angiogenesis.

Authors:  Bahar Yetkin-Arik; Ilse M C Vogels; Patrycja Nowak-Sliwinska; Andrea Weiss; Riekelt H Houtkooper; Cornelis J F Van Noorden; Ingeborg Klaassen; Reinier O Schlingemann
Journal:  Sci Rep       Date:  2019-08-30       Impact factor: 4.379

5.  Difficulties in recognition of pyruvate dehydrogenase complex deficiency on the basis of clinical and biochemical features. The role of next-generation sequencing.

Authors:  E Ciara; D Rokicki; P Halat; A Karkucińska-Więckowska; D Piekutowska-Abramczuk; J Mayr; J Trubicka; T Szymańska-Dębińska; M Pronicki; M Pajdowska; M Dudzińska; M Giżewska; M Krajewska-Walasek; J Książyk; W Sperl; R Płoski; E Pronicka
Journal:  Mol Genet Metab Rep       Date:  2016-04-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.